AAREYDRUGS — Aarey Drugs and Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.42bn
- IN₹1.70bn
- IN₹3.96bn
- 32
- 55
- 45
- 38
Annual cashflow statement for Aarey Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 72.4 | 83 | 100 | 60.1 | 53.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 17.9 | 24.3 | 20 | 28.7 | 43.8 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -70.6 | -61.8 | -185 | -117 | -133 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 28.6 | 54.8 | -44.9 | -12.8 | -25.8 |
| Capital Expenditures | -9.19 | -28.8 | -22 | -10.4 | -7.22 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.046 | 14.8 | -9.8 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -9.19 | -28.8 | -22 | 4.41 | -17 |
| Financing Cash Flow Items | -17.9 | -24.3 | -20 | -28.7 | -44.2 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -18 | -24.5 | 62.3 | 13.5 | 51.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.34 | 1.47 | -4.58 | 5.14 | 8.89 |